The American Journal of Medicine
Volume 121, Issue 11 , Pages 997-1001, November 2008

Clinical Outcome of Patients with Heart Failure and Preserved Left Ventricular Function

  • Israel Gotsman, MD

      Affiliations

    • Heart Institute, Hadassah University Hospital, Jerusalem, Israel
    • Corresponding Author InformationRequests for reprints should be addressed to Israel Gotsman, MD, Heart Institute, Hadassah University Hospital, POB 12000, Jerusalem, Israel IL-91120
  • ,
  • Donna Zwas, MD

      Affiliations

    • Heart Institute, Hadassah University Hospital, Jerusalem, Israel
  • ,
  • David Planer, MD

      Affiliations

    • Heart Institute, Hadassah University Hospital, Jerusalem, Israel
  • ,
  • Tanya Azaz-Livshits, PhD

      Affiliations

    • Department of Clinical Pharmacology, Hadassah University Hospital, Jerusalem, Israel
  • ,
  • Dan Admon, MD

      Affiliations

    • Heart Institute, Hadassah University Hospital, Jerusalem, Israel
  • ,
  • Chaim Lotan, MD

      Affiliations

    • Heart Institute, Hadassah University Hospital, Jerusalem, Israel
  • ,
  • Andre Keren, MD

      Affiliations

    • Heart Institute, Hadassah University Hospital, Jerusalem, Israel

Abstract 

Background

Patients with heart failure have a poor prognosis. However, it has been presumed that patients with heart failure and preserved left ventricular function (LVF) may have a more benign prognosis.

Objectives

We evaluated the clinical outcome of patients with heart failure and preserved LVF compared with patients with reduced function and the factors affecting prognosis.

Methods

We prospectively evaluated 289 consecutive patients hospitalized with a definite clinical diagnosis of heart failure based on typical symptoms and signs. They were divided into 2 subsets based on echocardiographic LVF. Patients were followed clinically for a period of 1 year.

Results

Echocardiography showed that more than one third (36%) of the patients had preserved systolic LVF. These patients were more likely to be older and female and have less ischemic heart disease. The survival at 1 year in this group was poor and not significantly different from patients with reduced LVF (75% vs 71%, respectively). The adjusted survival by Cox regression analysis was not significantly different (P=.25). However, patients with preserved LVF had fewer rehospitalizations for heart failure (25% vs 35%, P<.05). Predictors of mortality in the whole group by multivariate analysis were age, diabetes, chronic renal failure, atrial fibrillation, residence in a nursing home, and serum sodium135 mEq/L.

Conclusion

The prognosis of patients with clinical heart failure with or without preserved LVF is poor. Better treatment modalities are needed in both subsets.

Keywords: Heart failure, Outcome, Preserved left ventricular function, Survival

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Funding source: The Louis Chor Memorial Trust Award for research in Cardiac Disease.

 Conflict of interest statement for all authors: There is no conflict of interests.

 Authorship: The work is original and all authors meet the criteria for authorship, including acceptance of responsibility for the scientific content of the article. All authors had access to the data and a role in writing the article.

PII: S0002-9343(08)00705-5

doi:10.1016/j.amjmed.2008.06.031

The American Journal of Medicine
Volume 121, Issue 11 , Pages 997-1001, November 2008